FIELD: medicine.
SUBSTANCE: method for prevention of ixodic tick-borne borreliosis in children by an antibacterial therapy consists in the fact that after establishing the fact of Borrelia infected tick suction, ceftriaxone 50 mg/kg a day is injected intramuscularly for 3 days in a combination with a single intramuscular injection of bicillin 5 in a dose of 50 thousand IU/kg; anaferone is also prescribed in a dose of 1 tablet 3 times a day for 30 days.
EFFECT: method provides efficacy and safety that promotes reducing the incidence of ixodic borreliosis.
1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PROPHYLAXIS OF IXODOIDEA TICK BORRELIOSIS | 1997 |
|
RU2143904C1 |
METHOD FOR TREATMENT OF ACUTE TICK BORRELIOSIS ON BACKGROUND OF CHRONIC OPISTHORCHIASIS | 2004 |
|
RU2289400C2 |
METHOD FOR TREATING IXODIC TICK-BORNE BORRELIOSIS IN CHILDREN | 2002 |
|
RU2226393C2 |
METHOD OF LEUKOENCEPHALITIS TREATMENT IN CHILDREN | 2007 |
|
RU2348411C2 |
METHOD FOR PROPHYLAXIS OF TICK-BORNE ENCEPHALITIS IN CHILDREN | 2005 |
|
RU2281784C1 |
DIAGNOSTIC TECHNIQUE FOR TICK-BORNE BORRELIOSIS | 2009 |
|
RU2395814C1 |
METHOD FOR PREDICTING RISK OF DEVELOPMENT OF NEUROLOGICAL COMPLICATIONS IN ADULT PATIENTS WITH ERYTHEMIC FORM OF IXODID TICK BORREOLISIS | 2015 |
|
RU2611354C1 |
BACTERIUM STRAIN Borrelia garinii BgVir-1 FOR PREPARATION OF DRUGS FOR DIAGNOSIS AND PROPHYLAXIS OF IXODIC MITE-BORN BORRELIOSIS AND FOR EVALUATION OF PROTECTIVE AND SPECIFIC ACTIVITY OF PROPHYLAXIS AND THERAPEUTIC AGENTS | 2005 |
|
RU2295564C2 |
METHOD FOR ASSESSING LIKELIHOOD OF PATIENT DEVELOPING VARIANTS OF TICK-BORNE INFECTIONS: NON-ERYTHEMATOUS FORM OF IXODID TICK-BORNE BORRELIOSIS OR COMBINED COURSE OF BORRELIOSIS-ENCEPHALITIS INFECTION | 2017 |
|
RU2647450C1 |
METHOD OF EVALUATING THE PROBABILITY OF THE OUTCOMES OF THE ERYTHEMATOUS FORM OF LYME BORRELIOSIS | 2017 |
|
RU2660572C1 |
Authors
Dates
2014-06-10—Published
2012-12-29—Filed